Evaluation of (R)-Roscovitine Safety and Effects in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

NCT02649751 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
49
Enrollment
OTHER
Sponsor class

Stopped The centers have no longer patients. In September 2018, set up of a competitive international study.

Conditions

Interventions

Sponsor

University Hospital, Brest

Collaborators